Long-term efficacy of combination therapy with PEG-IFN and entecavir on HBsAg loss and anti-HBs seroconversion in patients with chronic active hepatitis
63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 9 - 13 November 2012, vol.56, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Volume: 56
- City: Massachusetts
- Country: United States Of America
- Inonu University Affiliated: Yes